Emerging evidence suggests that hyperphosphorylation of 4E-BPs leading to enhanced eIF4E activity is linked to malignant progression in breast, ovarian, prostate and colon cancers37–39. The gene discussed is EIF4E; the disease is digestive system neoplasm.